Penserra Capital Management LLC Novartis Ag Transaction History

Penserra Capital Management LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 13, 2024	BUY	$92.57 - $107.37 $355,376 - $412,193	3,839 Added 19.17%	23,863 $2.54 Million
Q1 2024 May 15, 2024	BUY	$95.27 - $108.47 $389,463 - $443,425	4,088 Added 25.65%	20,024 $1.94 Million
Q4 2023 Feb 14, 2024	BUY	$92.27 - $101.54 $474,452 - $522,118	5,142 Added 47.64%	15,936 $1.61 Million
Q3 2023 Nov 15, 2023	BUY	$94.73 - $105.13 $502,163 - $557,294	5,301 Added 96.5%	10,794 $1.1 Million
Q2 2023 Aug 11, 2023	BUY	$92.52 - $104.91 $175,417 - $198,909	1,896 Added 52.71%	5,493 $554,000
Q1 2023 Apr 24, 2023	BUY	$80.03 - $92.81 $209,358 - $242,790	2,616 Added 266.67%	3,597 $330,000
Q4 2022 Feb 13, 2023	BUY	$75.55 - $92.52 $38,077 - $46,630	504 Added 105.66%	981 $88,000
Q3 2022 Nov 14, 2022	BUY	$74.61 - $87.26 $35,588 - $41,623	477 New	477 $36,000

1,437

131M

1.12M

1.83M

Ticker NVS
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,151,000,064
Market Cap $212B
Description
Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...

Get notified when there are updates to the investment portfolio of Penserra Capital Management LLC, based on Form 13F filings with the SEC.

Stay updated on Penserra Capital Management LLC with notifications on news.